FFM
NVO

Fullerton Fund Management’s Novo Nordisk NVO Stock Holding History

Fullerton Fund Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,306
Closed -$264K – 86
2021
Q2 		$264K Sell
6,306
-3,522
-36% -$137K 0.02% 72
2021
Q1 		$331K Sell
9,828
-2,888
-23% -$103K 0.03% 69
2020
Q4 		$444K Buy
12,716
+7,390
+139% +$255K 0.03% 74
2020
Q3 		$185K Buy
+5,326
New +$178K 0.02% 63

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fullerton Fund Management's NVO Position: Q3 2021 in Review

Fullerton Fund Management sold out of Novo Nordisk (NVO) in Q3 2021, closing a stake of 6,306 shares — an estimated $264K sold.

Fullerton Fund Management first reported a position in NVO in Q3 2020 and held it in 4 quarters. The position peaked at $444K in Q4 2020. 804 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

  • Fullerton Fund Management reported no remaining Novo Nordisk position as of Q3 2021 after selling out during the quarter.
  • Fullerton Fund Management sold 6,306 Novo Nordisk shares in Q3 2021, an estimated $264K.
  • Fullerton Fund Management first reported a position in Novo Nordisk in Q3 2020 and held it in 4 quarters.
  • Fullerton Fund Management's Novo Nordisk position peaked at $444K in Q4 2020.
  • 804 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Fullerton Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.